Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study

BMC Pregnancy and Childbirth

Volumn 12, Issue , 2012, Pages

  Myer, Landon ^a   Zulliger, Rose ^b   Bekker, Linda Gail ^a   Abrams, Elaine ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Columbia University ^*  (United States)

Author keywords

Antiretroviral therapy; HIV AIDS; Patient preparation; Pregnancy; Prevention of mother to child transmission (PMTCT); South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATIENT COUNSELING; PATIENT EDUCATION; PREGNANCY; PREGNANT WOMAN; PRENATAL SCREENING; RETROSPECTIVE STUDY; THERAPY DELAY; TREATMENT OUTCOME;

ANTI-RETROVIRAL AGENTS; COHORT STUDIES; COUNSELING; FEMALE; HIV SEROPOSITIVITY; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; SOUTH AFRICA; TIME FACTORS;

EID: 84865975653     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-12-94     Document Type: Article

References (34)

1. UNAIDS Global report: UNAIDS report on the global AIDS epidemic, 2010 2010, UNAIDS: UNAIDS/10.11E | JC1958E, Geneva, UNAIDS.
2. South African National Department of Health The 2010 National Antenatal Sentinel HIV & Syphilis Prevalence Survey in South Africa 2011, Directorate: Epidemiology & Surveillance, National Department of Health, Pretoria, 2992617, 21113037, South African National Department of Health.
3. Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Mwiya M, Thea DM. Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to-child HIV transmission. AIDS 2010, 24:1374-1377. 2946203, 20568677.
4. Abrams EJ, Myer L, Rosenfield A, El-Sadr WM. Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences. Am J Obstet Gynecol 2007, 197:S101-S106.
5. European Collaborative Study Time to Undetectable Viral Load after Highly Active Antiretroviral Therapy Initiation among HIV-Infected Pregnant Women. Clin Infect Dis 2007, 44:1647-1656. European Collaborative Study.
6. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008, 22:973-981. 10.1097/QAD.0b013e3282f9b67a, 18453857.
7. Fitzgerald FC, Bekker L-G, Kaplan R, Myer L, Lawn SD, Wood R. Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. S Afr Med J 2010, 100:827-831.
8. Hoffman RM, Black V, Technau K, Van Der Merwe KJ, Currier J, Coovadia A, Chersich M. Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2010, 54:35-41. 2880466, 20216425.
9. Chibwesha CJ, Giganti MJ, Putta N, Chintu N, Mulindwa J, Dorton BJ, Chi BH, Stringer JS, Stringer EM. Optimal Time on HAART for Prevention of Mother-to-Child Transmission of HIV. J Acquir Immune Defic Syndr 2011, 58:224-228. 10.1097/QAI.0b013e318229147e, 21709566.
10. Myer L. Initiating antiretroviral therapy in pregnancy: the importance of timing. J Acquir Immune Defic Syndr 2011, 58:125-126. 10.1097/QAI.0b013e31822ad573, 21799436.
11. Ferguson L, Grant AD, Watson-Jones D, Kahawita T, Ong'ech JO, Ross DA. Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic review. Trop Med Int Health 2012, 17:564-580. 10.1111/j.1365-3156.2012.02958.x, 22394050.
12. Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health 2010, 15:825-832. 10.1111/j.1365-3156.2010.02538.x, 20497405.
13. Carter RJ, Dugan K, El-Sadr WM, Myer L, Otieno J, Pungpapong N, Toro PL, Abrams EJ. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. J Acquir Immune Defic Syndr 2010, 55:404-410. 10.1097/QAI.0b013e3181e73f4b, 20595905.
14. Myer L, Zulliger R, Pienaar D. Diversity of patient preparation activities before initiation of antiretroviral therapy in Cape Town, South Africa. Tropical Medicine & International Health in press.
15. Kwaan L, Kindra G, Mdutyana L, Coutsoudis A. Prevention is better than cure - the art of avoiding non-adherence to antiretroviral treatment. Southern African Journal of HIV Medicine 2010, 11:8-11.
16. Gebrekristos HT, Mlisana KP, Karim QA. Patients' readiness to start highly active antiretroviral treatment for HIV. BMJ 2005, 331:772-775. 10.1136/bmj.331.7519.772, 1239986, 16195299.
17. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004, 18(Suppl 3):S27-S31.
18. Siedner MJ, Lankowskei A, Haberer J, Kembabazi A, Emenyonu N, Tsai AC, Muzoora C, Geng E, Martin JN, Bangsberg DR. Rethinking the " Pre" in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs. PLoS One 2012, 7:e39894. 10.1371/journal.pone.0039894, 3383698, 22761924.
19. Bekker LG, Orrell C, Reader L, Matoti K, Cohen K, Martell R, Abdullah F, Wood R. Antiretroviral therapy in a community clinic-early lessons from a pilot project. S Afr Med J 2003, 93:458-462.
20. Bekker LG, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J 2006, 96:315-320.
21. Read PJ, Mandalia S, Khan P, Harrisson U, Naftalin C, Gilleece Y, Anderson J, Hawkins DA, Taylor GP, de Ruiter A. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?. AIDS 2012, 26:1095-103. 10.1097/QAD.0b013e3283536a6c, 22441248.
22. Stinson K, Myer L. Barriers to initiating antiretroviral therapy during pregnancy: a qualitative study of women attending services in Cape Town, South Africa. African Journal of AIDS Research 2012, 11:65-73.
23. Grimes RM, Grimes DE. Readiness: the state of the science (or the lack thereof). Curr HIV/AIDS Rep 2010, 7:245-252. 10.1007/s11904-010-0056-2, 2989238, 20714831.
24. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005, 19:2141-2148. 10.1097/01.aids.0000194802.89540.e1, 16284464.
25. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010, 362:697-706. 10.1056/NEJMoa0905848, 3076221, 20181971.
26. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008, 359:2233-2244. 10.1056/NEJMoa0800971, 2950021, 19020325.
27. Makadzange AT, Ndhlovu CE, Takarinda K, Reid M, Kurangwa M, Gona P, Hakim JG. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. Clin Infect Dis 2010, 50:1532-1538. 10.1086/652652, 20415574.
28. Zolfo M, Anja, Schouten E, Lynen L. Time for " Test and Treat" in Prevention of Mother-to-Child Transmission Programs in Low- and Middle-Income Countries. J Acquir Immune Defic Syndr 2010, 55:287-289. 10.1097/QAI.0b013e3181eef3da, 20714271.
29. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, Harries AD, van Oosterhout JJ, Meguid T, Ben-Smith A, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 2011, 378:282-284. 10.1016/S0140-6736(10)62303-3, 21763940.
30. Greenland S, Neutra R. Control of confounding in the assessment of medical technology. Int J Epidemiol 1980, 9:361-367.
31. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009, 360:1815-1826. 10.1056/NEJMoa0807252, 2854555, 19339714.
32. Bosco JL, Silliman RA, Thwin SS, Geiger AM, Buist DS, Prout MN, Yood MU, Haque R, Wei F, Lash TL. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol 2010, 63:64-74. 10.1016/j.jclinepi.2009.03.001, 2789188, 19457638.
33. Coutsoudis A, England K, Rollins N, Coovadia H, Newell M-L, Bland R. Women' s morbidity and mortality in the first 2 years after delivery according to HIV status. AIDS 2010, 24:2859-2866. 10.1097/QAD.0b013e32834041b7, 20935552.
34. Myer L, Zulliger R, Black S, Pienaar D, Bekker LG. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa. AIDS Care 2012, 24:986-992. 10.1080/09540121.2012.668173, 22519561.